跳至主要内容
临床试验/IRCT20151017024572N24
IRCT20151017024572N24尚未招募3 期

ltrasound-guided Prolotherapy, Oxygen-ozone and corticosteroid injection for the treatment of plantar fasciitis: A randomized, double-blind, multi-center study.

Iran University of Medical Sciences0 个研究点目标入组 42 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • More than three months of heel pain (in medial aspect) which is worst with the first few steps after awakening.
  • Pain and tenderness elicited by palpation of the medial calcaneal or the proximal plantar fascia.
  • Visual analog scale (VAS) score greater than or equal to 4.
  • Sonographic plantar fascia thickness greater than 4 mm with hypoechoic change at insertion point to the calcaneus.

排除标准

  • History of ankle or calcaneal trauma.
  • Positive Tinel’s sign on the tibial nerve (posterior to medial malleoli).
  • History of systemic inflammatory or connective tissue disease such as rheumatoid arthritis.
  • History of lumbar disc herniation with S1 radiculopathy.
  • History of gout.
  • Uncontrolled diabetes.
  • History of heel surgery or injections in the last six months.
  • Cystic or mass lesion at the site of the painful heel.
  • History of paresthesia, numbness or peripheral neuropathy.
  • Coagulation disorder.
  • Allergic reaction to Corticosteroid or Dextrose or Ozone.
  • Infection at the injection site.
  • Posterior heel pain.
  • Initiation of PF treatment within 10 days before intervention such as anti-inflammatory drug therapy, physical therapy.
  • History of vascular insufficiency causing heel pain.

研究者

相似试验